CoChat
Sign Up
Cited by 234Adrenal Hormones and DisordersMetabolism and Genetic DisordersStress Responses and Cortisol

The DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index.

Adrenocorticotropin Insensitivity Syndromes

Clark, Adrian J. L., Weber, Angela·1998·Endocrine Reviews
DOI 10.1210/edrv.19.6.0351
Open this paper in CoChat — free account

Abstract

I. Introduction II. Familial Glucocorticoid Deficiency A. Clinical presentation B. Investigation C. Treatment D. Pathogenesis III. Triple A Syndrome A. Clinical features B. Treatment C. Pathogenesis D. Mapping of triple A syndrome gene E. Candidate genes IV. Acquired ACTH Resistance V. Conclusions ACTH INSENSITIVITY syndromes comprise an uncommon group of disorders that, current evidence suggests, have at least three different molecular etiologies. The aim of this review is to examine the various forms of clinical presentation in conjunction with the current knowledge of the molecular and genetic background of these diseases, which as will be seen, reveals some interesting and unexpected physiological and anatomical relationships. The principal pathways by which ACTH stimulates adrenal steroidogenesis are summarized in Fig. 1. The syndrome of ACTH insensitivity was originally described by Shepard et al. (1) in 1959 in a paper entitled “Familial Addison’s Disease,” which reported the case of two sisters who had what has subsequently become known most frequently as familial glucocorticoid deficiency, isolated glucocorticoid deficiency, adrenal unresponsiveness to ACTH, or hereditary unresponsiveness to ACTH. For uniformity, and since it was the first of these terms to be coined and has been most frequently used in the literature, we continue to refer to this disorder as familial glucocorticoid deficiency (FGD), although the other terms are equally descriptive (MIM*202200). Essential features of the mechanism of action of ACTH in stimulating steroidogenesis in the adrenal fasciculata cell. ACTH binds to and activates its cognate seven-transmembrane domain receptor at the cell surface, resulting in activation of the heterotrimeric G protein by exchange of GTP for GDP and dissociation of the α-subunit from the βγ-subunits. Gsα then stimulates membrane-associated adenylate cyclase to synthesize cAMP, which in turn activates protein kinase A (PKA) in the cytosol. The catalytic subunits of PKA dissociate and phosphorylate target factors, which include the cAMP response element binding protein (CREB). CREB and other unidentified factors which may also be substrates for PKA then activate the steroidogenic acute regulatory protein (StAR) protein and induce the transcription of the steroidogenic enzymes CYP11A (P450 scc), CYP17 (17α-hydroxylase), CYP21 (21-hydroxylase), and CYP11B1 (11β-hydroxylase), which ultimately results in an increased rate of cortisol synthesis. Although it had been recognized previously as a variant of FGD, the other distinct syndrome of ACTH insensitivity that we shall discuss was identified as such in a paper by Allgrove et al. in 1978 (2). This syndrome became known as Allgrove syndrome or, more recently, as the triple A syndrome for reasons that will be described. As we shall show, this is a distinct clinical and genetic entity that shares with FGD only the feature of ACTH insensitivity. The typical presentation of patients with ACTH insensitivity is almost always as a consequence of glucocorticoid deficiency. Excessive skin pigmentation as a result of high circulating ACTH is occasionally reported as one of the primary complaints. Since these disorders are inherited diseases (see below), it might be expected that glucocorticoid deficiency should be manifest in the neonatal period. Although this is true for some patients, many are not diagnosed until infancy or later childhood. The nature of the clinical presentation in the neonate differs from that in later childhood and in most patients takes the form of hypoglycemia (3–8). This may not be profound and usually responds to more frequent feeding. Often these patients are significantly jaundiced and may require phototherapy (4, 5, 7, 8). In some cases this appears to result from a transient hepatitis, which may be glucocorticoid dependent (9). Perhaps surprisingly, excessive pigmentation of the skin is occasionally seen the first of although this is usually first and or as is a feature in infancy and childhood. may at this with a that may be will frequent which an to feature of FGD is childhood which responds to of glucocorticoid a of other features frequent and to and skin pigmentation be features be with a of childhood Addison’s and in many patients this is the FGD differs from Addison’s in one patients with FGD deficiency, and of and This the that by the adrenal is the of and is of ACTH, although ACTH in the of the adrenal are the of ACTH. In and are from the from of in the known as Although to the for it is that ACTH is for adrenal since patients with FGD evidence of an and have adrenal patients with the clinical of FGD have been reported to be 7, for this has been and not to have been of the of the patients a of or adrenal or other with adrenal resulting from other such as Addison’s are not and the excessive usually clinical is in these patients, and the in This may be of in the of the (see The described should to a of an to which in the

Overview

Integrity signals

Registry

Crossref · 10.1210/edrv.19.6.0351

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

1 of the 122 references couldn’t be matched to a known paper.

Research works printed but not linked: 13

  1. Elias, 1997, Functional analysis of the I44M mutant ACTH receptor found in familial glucocorticoid deficiency., J Endocrinol, 155, 29
  2. Petrykowski, 1975, Familiäre Glucocorticoidinsuffizienz., Klin Padiatr, 187, 198
  3. Yordam, 1996, Familial glucocorticoid deficiency: clinical spectrum and endocrine details in five Turkish children, Horm Res, 46, 92
  4. Hammami, 1989, Association d’une maladie d’Addison, d’une achalasie du cardia et d’une alacrymation. A propos de deux observations., Ann Pediatr (Paris), 36, 279
  5. Várkonyi Á, Jukesz, 1992, Simultaneous occurrence of selective ACTH insensitivity, achalasia and alacrima accompanied by hyperlipoproteinaemia., Acta Paediatr Hung, 32, 31
  6. Degli Esposti, 1985, Sindrome familiare di ipoglicocorticismo da insensibilatà all’ACTH, acalasia, alacrima, con associata neuromiopatia distale., Minerva Pediatr, 37, 353
  7. Weber, 1997, Clinical variability and molecular genetics in a family with triple A syndrome, Horm Res, 48, 191
  8. Rezvani, 1983, Familial glucocorticoid deficiency (FGD) with lacrimal and esophageal dysfunction: evidence against an ACTH “receptor defect.”, Pediatr Res, 17, 170
  9. Auge, 1985, Addison’s disease in littermates., Vet Med (Praha), 80, 43
  10. Acta Neurobiol Exp (Warsz), 50, 353
  11. Johnson, 1983, Autonomic failure and the eyes, In: Bannister R (ed) Autonomic Failure. A Textbook of Clinical Disorders of the Autonomous Nervous System. Oxford University Press, Oxford, UK, pp, 509
  12. Krauter, 1995, A second-generation YAC contig map of human chromosome 12, Nature, 377, 321
  13. Kucherlapati, Cytogenet Cell Genet, 78, 82

Cited by

Sorted by citations

See all 234

Related

See all

Metadata

Authors
Clark, A. J. L., & Weber, A.
Affiliations
  • St Bartholomew's Hospital (GB)
  • Technische Universität Dresden (DE)
Venue
Endocrine Reviews
Publisher
The Endocrine Society
Published
1998-12-01
Volume
19
Issue
6
Pages
828-843
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
DOI
10.1210/edrv.19.6.0351
OpenAlex
W2117973418
Cited by
234
References
122
Citations by year
2026: 3 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 7 · 2020: 9 · 2019: 3 · 2018: 9 · 2017: 12 · 2016: 2 · 2015: 10 · 2014: 10 · 2013: 8 · 2012: 9
FWCI
1.16
Type
journal article
Language
en
Open access
closed
Locations
  • Endocrine Reviews (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • Deutsche Forschungsgemeinschaft
  • Albert-Ludwigs-Universität Freiburg
  • Hospital for Sick Children
  • Universität Zürich
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
familial glucocorticoid deficiency, triple A syndrome, ACTH receptor, G protein signaling, steroidogenesis, adrenal cortex, steroidogenic acute regulatory protein, CREB, CYP11A, CYP17, CYP21, CYP11B1
MeSH terms
Adrenal Glands, Adrenocorticotropic Hormone, Animals, Humans, Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review